BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Apr 27, 2026; 18(4): 117456
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.117456
Novel nomogram for differential diagnosis of UGT1A1 gene mutation-associated unconjugated hyperbilirubinemia with hemolytic diseases
Hai-Tian Yu, Mei-Han Li, Shan Tang, Chen Liang, Da-Cheng Sheng, Hui Jiang, Jian-Xia Dong, Wei Hou, Su-Jun Zheng
Hai-Tian Yu, Mei-Han Li, Shan Tang, Da-Cheng Sheng, Hui Jiang, Jian-Xia Dong, Wei Hou, Su-Jun Zheng, Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
Chen Liang, Department of Gastroenterology, Beijing Jishuitan Hospital, Capital Medical University, Beijing 102208, China
Co-first authors: Hai-Tian Yu and Mei-Han Li.
Author contributions: Yu HT, Li MH, Tang S, Liang C, Sheng DC, Jiang H, and Dong JX collected the data; Yu HT, Li MH, Liang C, and Hou W performed the statistical analysis; Yu HT wrote the original draft; Li MH, Tang S, and Zheng SJ reviewed and edited the manuscript; Yu HT and Li MH contributed equally to this manuscript as co-first authors; Zheng SJ designed the study. All authors approved final revision of the paper.
Supported by the National Key Research and Development Program of Ministry of Science and Technology, No. 2022YFC2304400; Beijing Hospitals Authority’s Ascent Plan, No. DFL20241701; and High-Level Public Health Technical Talents of the Beijing Municipal Health Commission, No. Academic Leader-02-14.
Institutional review board statement: All procedures involving human participants were in accordance with the ethical standards of the Institute Ethical Committee of Beijing YouAn Hospital, Capital Medical University, Beijing, China, and with the Helsinki Declaration (approval No. LL-2025-041-K).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The datasets used and analysed during the current study are available from the corresponding author on reasonable request.
Corresponding author: Su-Jun Zheng, MD, PhD, Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, No. 8 Xitoutiao, Youwai Street, Fengtai District , Beijing 100069, China. zhengsujun@ccmu.edu.cn
Received: December 8, 2025
Revised: January 20, 2026
Accepted: March 3, 2026
Published online: April 27, 2026
Processing time: 134 Days and 22.7 Hours
Core Tip

Core Tip: Clinical characteristic overlap and the need for complex specialized testing make it challenging to distinguish uridine diphosphate glucuronosyltransferase 1A1 mutations from hemolytic diseases in patients with chronic unconjugated hyperbilirubinemia. In a genetically confirmed cohort, we applied least absolute shrinkage and selection operator and logistic regression to identify four variables for differential diagnosis: Abnormal peripheral blood smear, hematocrit, red cell distribution width standard deviation, and reticulocyte percentage. These variables were used to establish a nomogram model, which achieved an area under the receiver operating characteristic curve of 0.986 and an area under precision-recall curve of 0.938. This model provides a simple, interpretable, and cost-effective tool for early screening and triage, potentially reducing the need for complex testing.